Product Information

RAMELTEON 8 MG TABLET is a generic product labeled by TruPharma LLC, priced at $0.6660 per EA under NDC 52817023510. Its NADAC has been published 319 times since Oct 7, 2020.

FDA first approved this application on Apr 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RAMELTEON 8 MG TABLET

Ramelteon
$0.6660per EA

Strength

8 mg/1

Manufacturer

TruPharma LLC

NDC

52817023510

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RAMELTEON

Approval Type

Generic (ANDA)

FDA Application

ANDA212650

FDA Approved

4/10/2020

TE Code

AB

On Market Since

6/30/2020

Pharmacological Classes

Melatonin Receptor Agonist
Melatonin Receptor Agonists

Price Statistics

The NADAC for RAMELTEON 8 MG TABLET has been published 319 times since Oct 7, 2020, and over the history we have for it it has declined 81.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6660 per EA
All-time high$3.5093 (Oct 14, 2020)
All-time low$0.5491 (Nov 20, 2024)
52-week high$0.7622
52-week low$0.6575
Median price$0.9280
Average price$1.1743
Largest weekly change+50.1% (Aug 21, 2024)
Weeks tracked319
Tracking sinceOct 7, 2020

Price History

1W

0.0%

1M

+0.9%

3M

+1.3%

6M

-6.8%

1Y

-8.4%

3Y

-30.5%

5Y

-54.3%

All

-81.0%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RAMELTEON 8 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RAMELTEON 8 MG TABLET, manufactured by TruPharma LLC, is $0.6660 per EA (NDC 52817023510), effective Nov 11, 2026.

How has the price of RAMELTEON 8 MG TABLET changed over time?

Over the history we have for it, the NADAC for RAMELTEON 8 MG TABLET has declined 81.0%. It has been tracked across 319 weekly CMS publications since Oct 7, 2020.

What are the highest and lowest recorded NADAC prices for RAMELTEON 8 MG TABLET?

Since Oct 7, 2020, the NADAC for RAMELTEON 8 MG TABLET has ranged from a low of $0.5491 (Nov 20, 2024) to a high of $3.5093 (Oct 14, 2020), with a median of $0.9280 per EA.

Are there cheaper alternatives to RAMELTEON 8 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAMELTEON 8 MG TABLET, is $0.6575 per EA — about 1% below RAMELTEON 8 MG TABLET.

Who manufactures RAMELTEON 8 MG TABLET?

RAMELTEON 8 MG TABLET (NDC 52817023510) is labeled by TruPharma LLC, and CMS classifies it as a generic product.